Distinct iris gene expression profiles of primary angle closure glaucoma and primary open angle glaucoma and their interaction with ocular biometric parameters
Male
biometrics
570
Iridectomy
Biometry
Anterior Chamber
Gonioscopy
610
Iris
INTRAOCULAR-PRESSURE
Collagen Type I
03 medical and health sciences
0302 clinical medicine
VESSELS
Lens, Crystalline
EXTRACELLULAR-MATRIX
TISSUE-REPAIR
Humans
POAG
AQUEOUS-HUMOR
Prospective Studies
GENOME-WIDE ASSOCIATION
Eye Proteins
Intraocular Pressure
iris
Aged
Aged, 80 and over
Science & Technology
Gene Expression Profiling
PACG
SPARC
Original Articles
Middle Aged
Collagen Type I, alpha 1 Chain
Ophthalmology
ENDOTHELIAL GROWTH-FACTOR
Female
Glaucoma, Angle-Closure
Life Sciences & Biomedicine
Glaucoma, Open-Angle
DOI:
10.1111/ceo.12743
Publication Date:
2016-03-18T11:50:23Z
AUTHORS (9)
ABSTRACT
AbstractBackgroundThis study aimed to evaluate differences in iris gene expression profiles between primary angle closure glaucoma (PACG) and primary open angle glaucoma (POAG) and their interaction with biometric characteristics.DesignProspective study.ParticipantsThirty‐five subjects with PACG and thirty‐three subjects with POAG who required trabeculectomy were enrolled at the Singapore National Eye Centre, Singapore.MethodsIris specimens, obtained by iridectomy, were analysed by real‐time polymerase chain reaction for expression of type I collagen, vascular endothelial growth factor (VEGF)‐A, ‐B and ‐C, as well as VEGF receptors (VEGFRs) 1 and 2. Anterior segment optical coherence tomography (ASOCT) imaging for biometric parameters, including anterior chamber depth (ACD), anterior chamber volume (ACV) and lens vault (LV), was also performed pre‐operatively.Main Outcome MeasuresRelative mRNA levels between PACG and POAG irises, biometric measurements, discriminant analyses using genes and biometric parameters.ResultsCOL1A1, VEGFB, VEGFC and VEGFR2 mRNA expression was higher in PACG compared to POAG irises. LV, ACD and ACV were significantly different between the two subgroups. Discriminant analyses based on gene expression, biometric parameters or a combination of both gene expression and biometrics (LV and ACV), correctly classified 94.1%, 85.3% and 94.1% of the original PACG and POAG cases, respectively. The discriminant function combining genes and biometrics demonstrated the highest accuracy in cross‐validated classification of the two glaucoma subtypes.ConclusionsDistinct iris gene expression supports the pathophysiological differences that exist between PACG and POAG. Biometric parameters can combine with iris gene expression to more accurately define PACG from POAG.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (41)
CITATIONS (19)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....